Methods of manufacturing drug-loaded substrates
View Patent ↗A substrate is modified by exposing the substrate to a densified fluid. The substrate may be a polymer or a metal alloy, and the densified fluid may be carbon dioxide. Uses of such substrate modification include impregnation of the substrate with one or more drugs, impregnation of microcellular particles, surface modification of the substrate, and formation of microcellular compositions.
1. A method for preparing antimicrobial-releasing medical catheter tubing, comprising:
contacting catheter tubing comprised of thermoplastic polyurethane elastomer or silicone elastomer with a densified fluid having one or more antimicrobial agents dissolved therein under conditions wherein the densified fluid permeates the catheter tubing;
removing the densified fluid from the catheter tubing to leave amounts of the one or more antimicrobial agents impregnated in the catheter tubing; and
dissolving additional amounts of the one or more antimicrobial agents into the densified fluid during said contacting step.
2. The method of claim 1 , wherein said dissolving additional amounts includes providing undissolved solids comprising the one or more antimicrobial agents within the densified fluid, such that at least some of the undissolved solids are dissolved in the densified fluid during said contacting step.
3. The method of claim 1 , wherein said one or more antimicrobial agents comprise rifampin or minocycline.
4. The method of claim 1 , wherein said one or more antimicrobial agents includes a combination of rifampin and minocycline.
5. A method for impregnating a polymer substrate with a pharmaceutical agent, comprising:
contacting the polymer substrate with a volume of densified fluid substantially saturated with one or more pharmaceutical agents, said contacting under conditions effective for impregnating the substrate with the one or more pharmaceutical agents; and
during said contacting, maintaining undissolved amounts of the one or more pharmaceutical agents in the volume of densified fluid so as to replenish the densified fluid with additional dissolved amounts of the one or more pharmaceutical agents.
6. The method of claim 5 wherein the polymer substrate is catheter tubing.
7. The method of claim 6 wherein the catheter tubing is comprised of thermoplastic polyurethane elastomer or silicone elastomer.
8. The method of claim 5 wherein the undissolved amounts are comprised of solid particulate.
9. The method of claim 8 which comprises, prior to said contacting, charging an amount of solid particulate comprising the one or more pharmaceutical agents to a reactor, and wherein said a volume of densified fluid substantially saturated with one or more pharmaceutical agents is provided by dissolving some but not all of said amount of solid particulate in a densified fluid in the reactor.
10. The method of claim 5 wherein the one or more pharmaceutical agents comprise rifampin and minocycline.
11. The method of claim 5 wherein said polymer substrate is catheter tubing comprised of thermoplastic polyurethane elastomer or silicone elastomer, wherein said undissolved amounts are comprised of solid particulate, wherein said one or more pharmaceutical agents comprise rifampin and minocycline, and wherein the densified fluid comprises supercritical carbon dioxide.
12. A method for impregnating a polymer substrate with a pharmaceutical agent, comprising:
contacting the polymer substrate with a first volume of densified fluid substantially saturated with one or more pharmaceutical agents, said contacting under conditions effective for impregnating the substrate with amounts of the one or more pharmaceutical agents;
removing fluid of said first volume from the polymer substrate so as to provide the one or more pharmaceutical agents impregnated in the polymer substrate at a first level;
contacting the polymer substrate with a second volume of densified fluid substantially saturated with the one or more pharmaceutical agents, said contacting under conditions effective for impregnating the polymer substrate with additional amounts of the one or more pharmaceutical agents; and
removing fluid of said second volume from the polymer substrate so as to provide the one or more pharmaceutical agents impregnated in the polymer substrate at a second level higher than the first level.
13. The method of claim 12 , wherein said polymer substrate is catheter tubing comprised of thermoplastic polyurethane elastomer or silicone elastomer, wherein said one or more pharmaceutical agents comprise rifampin and minocycline, and wherein the densified fluid comprises supercritical carbon dioxide.
14. The method of claim 12 , wherein said removing fluid steps comprise reducing pressure on the densified fluid to evaporate the fluid.
15. The method of claim 12 , wherein the first volume and the second volume comprise supercritical carbon dioxide and wherein the polymer substrate is catheter tubing comprised of thermoplastic polyurethane elastomer or silicone elastomer.
16. The method of claim 15 , wherein the one or more pharmaceutical agents comprise rifampin or minocycline.
17. A method for impregnating a polymer substrate with a pharmaceutical agent, comprising:
preconditioning the polymer substrate with a penetrating agent to provide a conditioned polymer substrate;
contacting the conditioned polymer substrate with a densified fluid containing one or more pharmaceutical agents, said contacting under conditions effective for impregnating the polymer substrate with the one or more pharmaceutical agents; and
wherein the penetrating agent comprises supercritical carbon dioxide free of the one or more pharmaceutical agents.
18. The method of claim 17 , wherein said polymer substrate is catheter tubing.
19. The method of claim 18 , wherein said catheter tubing is comprised of thermoplastic polyurethane elastomer or silicone elastomer.
20. The method of claim 17 , wherein said polymer substrate has a Shore A hardness of less than 80.
21. The method of claim 17 , wherein said one or more pharmaceutical agents comprise an antimicrobial agent.
22. The method of claim 21 , wherein said antimicrobial agent comprises rifampin or minocycline.
23. The method of claim 22 , wherein said antimicrobial agent comprises rifampin and minocycline.
24. A method for impregnating a polymer substrate with a pharmaceutical agent, comprising:
preconditioning the polymer substrate with a penetrating agent to provide a conditioned polymer substrate;
contacting the conditioned polymer substrate with a densified fluid containing one or more pharmaceutical agents, said contacting under conditions effective for impregnating the polymer substrate with the one or more pharmaceutical agents; and
wherein the penetrating agent comprises supercritical carbon dioxide free of the one or more pharmaceutical agents.
25. The method of claim 24 , wherein the polymer substrate is catheter tubing comprised of a thermoplastic polyurethane elastomer or silicone elastomer.
26. The method of claim 25 , wherein the one or more pharmaceutical agents comprise rifampin or minocycline.
27. The method of claim 26 , wherein the one or more antimicrobial agents comprise rifampin and minocycline.